Distinguish resistance, tolerance and a heterogeneous endpoint

Define the evidence boundary

Resistance, tolerance and persistence are distinct evidence concepts. Resistance concerns an increased ability to grow under an inhibitory agent relative to a susceptible comparison. Tolerance concerns slower killing without necessarily shifting the growth-inhibition threshold; persistence is a heterogeneous tolerant subpopulation rather than simply any infection that lasts a long time. These phenotype definitions do not by themselves identify one molecular mechanism.

Connect mechanism and measurement

Resistance mechanisms can involve altered targets, agent inactivation or changed entry/efflux. Tolerance and persistence can involve multiple physiological or genetic determinants; they are not defined solely by dormancy, and a heritable change can affect a tolerance trait too. Thus “genetic” versus “not genetic” is not a complete classification rule. The relevant growth/survival phenotype and its context must be distinguished.

The fictional endpoint begins with 1000 units: fraction f in a slow-response component has recorded retention 0.5, while the rest retains 0.01. These are interpreted existing records, not instructions to create, select or isolate survivors. Expected remaining count is 1000[(1−f)0.01+f 0.5]. The same endpoint can coexist with different independently supplied evidence about whether a shifted susceptibility persists or returns to baseline after a documented state reset.

A return to baseline is compatible with reversible state-dependent tolerance/persistence rather than proof of a stable inherited resistance shift, but it does not uniquely identify the cause. A persistent shifted growth-susceptibility record supports an inherited-change interpretation without assigning its sequence or mechanism. No organism, treatment conditions, regrowth protocol or clinical decision is supplied.

Reconstruct the original record

At f=0.2, the fast component contributes 8 remaining units and the slow component 100, total 108. The slow share is 100/108=25/27≈0.925926. Changing the supplied phenotype-history label does not change these endpoint counts; it changes the additional evidence available for interpretation.

Predict and investigate

Predict first: Why is one retained-count endpoint insufficient to classify resistance or persistence?

Reconstruct both component contributions and compare the same count under two supplied phenotype-history records. Name which growth-threshold or survival distinction must be established independently rather than inferred from the count.

Defend a changed case

Apply the mechanism to a changed boundary

Use f=0.1. Find both contributions and the slow share; can that share by itself prove a genetic resistance mechanism?

Retain the first response, units, uncertainty and any prior feedback exposure in the notebook before comparing this public explanation.

Compare a worked response

The fast contribution is 9 and slow 50, total 59, so slow share 50/59≈0.847458. The enriched slow component alone proves neither a shifted growth threshold nor a specific inherited mechanism.

Retain bounded evidence

Preserve the original source, first response, units, uncertainty and feedback exposure in the Microbiology evidence workspace. All numerical records are fictional. No culture, control-process execution, chemical preparation, genetic manipulation, resistance generation, participant testing or clinical decision is requested. Actual practical and independent learner competence remain separate.

Primary mechanism or evidence context, checked 31 October 2026. Original teaching and supplied records; no source operating procedures copied.